Respiratory Virus Panel

About DiagMetrics

DiagMetrics is an innovative diagnostics company developing a proprietary Mask-Based Diagnostic (MBD™) platform that collects exhaled breath condensate (EBC) for non-invasive testing. With a strong intellectual property portfolio including multiple issued and pending patents, the company is initially targeting rapid screening for tuberculosis and respiratory viruses (SARS/Flu/RSV) using lateral flow assays and advanced biosensors. Backed by NIH RADx funding and a partnership with MilliporeSigma, DiagMetrics aims to democratize diagnostics by making testing as simple as breathing, with applications extending to chronic disease monitoring and oncology.

About Atila Biosystems

Atila Biosystems is a private, pre-revenue diagnostics company founded in 2018 and based in Mountain View, California. The company's core innovation is its iAMP technology, a proprietary isothermal amplification method designed for high sensitivity, multiplexing, and ease of use in decentralized settings. Its initial pipeline targets high-impact areas including sexually transmitted infections (STIs), respiratory viruses, and oncology, with the goal of providing faster, more accessible, and more comprehensive diagnostic results than current PCR or lateral flow methods. The company is positioned to compete in the rapidly growing point-of-care and decentralized diagnostics market.

Therapeutic Areas